home / stock / casi / casi news

CASI News and Press, CASI Pharmaceuticals Inc. From 07/21/20

Stock Information
Company Name: CASI Pharmaceuticals Inc.
Stock Symbol: CASI
Market: NASDAQ
Website: casipharmaceuticals.com
Menu
CASI CASI Quote CASI Short CASI News CASI Articles CASI Message Board
Get CASI Alerts

News, Short Squeeze, Breakout and More Instantly...
CASI - CASI Pharmaceuticals Announces Proposed Public Offering Of Common Stock

ROCKVILLE, Md. and BEIJING , July 21, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it has commenced an underwritte...
CASI - CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program

ROCKVILLE, Md. and BEIJING , June 8, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that it submitted a Clinical Trial Ap...

CASI - CASI Pharmaceuticals To Present At The Jefferies 2020 Healthcare Conference

ROCKVILLE, Md. , and BEIJING , June 2, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-Wu He , Chairman & CEO ...

CASI - CASI Pharmaceuticals: 2-Year Price Lows Make For Intriguing Risk-On Buy

Investment Thesis CASI Pharmaceuticals (Casi) (CASI) is currently rated a "strong buy" by analysts who have set a consensus price target of $3.5. The stock currently trades at $1.67 after shedding 49% of its value since mid-January. Casi's share price has been volatile in the past (a goo...
CASI - CASI Pharmaceuticals EPS beats by $0.02, beats on revenue

CASI Pharmaceuticals (NASDAQ: CASI ): Q1 GAAP EPS of -$0.09 beats by $0.02 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CASI - CASI Pharmaceuticals Announces First Quarter 2020 Financial Results

ROCKVILLE, Md. and BEIJING , May 11, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the first quarter of ...

CASI - CASI Pharmaceuticals To Present at 2020 Solebury Trout Virtual Investor Conference

ROCKVILLE, Md. and BEIJING , April 7, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-Wu He , Chairman & CEO ...
CASI - Daily Insider Ratings Round Up 3/27/20

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most i...

CASI - Daily Insider Ratings Round Up 3/19/20

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

CASI - CASI Pharmaceuticals Inc (CASI) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool. CASI Pharmaceuticals Inc   (NASDAQ: CASI) Q4 2019 Earnings Call Mar 16, 2020 , 4:30 p.m. ET Operator Continue reading

Previous 10 Next 10